Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	84.35	37.23	85.39	43.99	57.21	87.13
Short-Term Investments	132.34	210.95	284.52	205.24	186.8	299.52
Cash & Short-Term Investments	216.69	248.19	369.91	249.23	244	386.65
Cash Growth	-35.73%	-32.91%	48.42%	2.14%	-36.89%	15.34%
Accounts Receivable	7.72	6.65	8.61	20.32	23.58	23.49
Other Receivables	32.44	32	31	28.72	37.26	13.04
Receivables	40.16	38.65	39.62	49.04	60.83	36.53
Prepaid Expenses	10.68	12.41	13.26	13.45	14.19	13.66
Restricted Cash	0.61	0.61	-	-	-	-
Total Current Assets	268.15	299.85	422.79	311.71	319.02	436.84
Property, Plant & Equipment	77.04	73.35	34.71	29.75	10.65	15.62
Long-Term Investments	-	-	-	29.29	108.42	32.63
Long-Term Deferred Tax Assets	-	-	-	-	-	0.35
Other Long-Term Assets	3.45	3.45	4.77	4.66	0.7	0.7
Total Assets	348.64	376.65	462.28	375.41	438.79	486.13
Accounts Payable	4.73	8	4.1	6	9.54	5.74
Accrued Expenses	10.58	13.55	18.34	20.94	22.43	14.16
Current Portion of Long-Term Debt	32.74	34.46	35.08	-	-	-
Current Portion of Leases	1.01	1.52	5.28	2.89	4.2	4.26
Total Current Liabilities	49.05	57.54	62.79	29.83	36.17	24.16
Long-Term Debt	131.09	136.13	160.85	1.42	1.51	1.48
Long-Term Leases	56.45	53.94	21.24	22.37	1.13	3.84
Other Long-Term Liabilities	0.24	0.23	0.66	0.45	0.56	1.08
Total Liabilities	236.83	247.84	245.54	54.08	39.36	30.55
Common Stock	0.21	0.21	0.21	0.21	0.2	0.2
Additional Paid-In Capital	456.96	451.34	424.69	398.03	351.03	326.96
Retained Earnings	-345.33	-323.04	-207	-73.18	48.58	127.57
Comprehensive Income & Other	-0.03	0.3	-1.17	-3.72	-0.38	0.84
Shareholders' Equity	111.82	128.81	216.74	321.33	399.43	455.58
Total Liabilities & Equity	348.64	376.65	462.28	375.41	438.79	486.13
Total Debt	221.29	226.06	222.44	26.69	6.84	9.58
Net Cash (Debt)	-4.6	22.13	147.47	251.83	345.58	409.71
Net Cash Growth	-	-84.99%	-41.44%	-27.13%	-15.65%	2.86%
Net Cash Per Share	-0.22	1.05	7.03	12.22	17.13	20.55
Filing Date Shares Outstanding	21.33	21.19	21.06	20.8	20.32	20.08
Total Common Shares Outstanding	21.33	21.19	21.06	20.79	20.24	20.08
Working Capital	219.1	242.32	360	281.89	282.85	412.68
Book Value Per Share	5.24	6.08	10.29	15.46	19.74	22.69
Tangible Book Value	111.82	128.81	216.74	321.33	399.43	455.58
Tangible Book Value Per Share	5.24	6.08	10.29	15.46	19.74	22.69
Machinery	19.88	19.92	19.14	16.79	16.32	15.82
Construction In Progress	1.28	22.75	1.27	2.56	0.02	-
Leasehold Improvements	35.73	13.98	13.8	7.28	7.14	7.09

Source: S&P Capital IQ. Standard template. Financial Sources.